Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6)

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6)

IMAGING OF THERAPY RESPONSE IN ONCOLOGY 

     FOREWORD

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):587-8

Imaging of therapy response in oncology

Chiti A., Oyen W. J. G.


     REVIEWS

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):589-602

Response assessment in oncology: limitations of anatomic response criteria in the era of tailored treatments

Carnaghi C., Sclafani F., Basilico V., Doherty M.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):603-19

CT and MRI in monitoring response: state-of-the-art and future developments

D’Ippolito G., Torres L. R., Saito Filho C. F., Ferreira R. M.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):620-32

18F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go

Herrmann K., Benz M. R., Krause B. J., Pomykala K. L., Buck A. K., Czernin J.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):633-47

Use of PET/CT to evaluate response to therapy in lymphoma

Zanoni L., Cerci J. J., Fanti S.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):648-54

Therapy response assessment in radiotherapy of lung cancer

Van Elmpt W., Pöttgen C., De Ruysscher D.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):655-70

Development of molecular techniques for imaging and treatment of tumors

Haberkorn U., Markert A., Eisenhut M., Mier W., Altmann A.


     ORIGINAL ARTICLES

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):671-9

Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies

Arosio M., Pasquali C., Crivellaro C., De Ponti E., Morzenti S., Guerra L., Crespi A., Messa C.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):680-7

Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study

Fuster D., Ayuso J. R., Poveda A., Cubedo R., Casado A., Martínez-Trufero J., López-Pousa A., Del Muro X. G., Lomeña F., Maurel J., Pons F.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 December;55(6):688-93

The relation between left ventricular ejection fraction and perfusion defect size by gated SPECT myocardial perfusion imaging in patients with coronary artery disease

Aljaroudi W., Mundkur M., Heo J., Iskandrian A. E.


top of page